Eric H Lee

Title: Eric H Lee: Innovator in Cancer Treatment

Introduction

Eric H Lee is a notable inventor based in Greenville, SC (US), recognized for his contributions to cancer treatment. With a focus on innovative methods for addressing breast cancer, he has secured 2 patents that highlight his expertise in the field.

Latest Patents

Lee's latest patents include a "Method for treating breast cancer with prolactin receptor agonists." This patent discloses compositions and methods useful for the treatment of cancer, particularly breast cancer. The methods and compositions involve human prolactin, which may be used alone or in conjunction with a cytotoxic agent. Additionally, the patent discusses the inclusion of growth hormone and placental lactogen, either alone or with a cytotoxic agent, where the cytotoxic agent may comprise a chemotherapeutic agent.

Another significant patent is the "Method for sensitizing cancer stem cells to cancer therapy." Similar to his previous work, this patent outlines compositions and methods for treating cancer, including breast cancer. It also emphasizes the role of human prolactin and its combination with cytotoxic agents, growth hormone, and placental lactogen.

Career Highlights

Eric H Lee is currently associated with Orbis Health Solutions, LLC, where he continues to develop innovative solutions for cancer treatment. His work is characterized by a commitment to advancing medical science and improving patient outcomes.

Collaborations

Lee collaborates with various professionals in the field, including his coworker, Wen Yuan Chen. Their combined efforts contribute to the ongoing research and development of effective cancer therapies.

Conclusion

Eric H Lee stands out as an influential inventor in the realm of cancer treatment, with a focus on innovative methods that leverage prolactin and other agents. His patents reflect a dedication to improving therapeutic strategies for breast cancer, showcasing his significant contributions to medical science.